REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/23/2026
Back to search
Official data from USPTO
ADRENOMED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ADRENOMED
ST13
US500000079279475Class
5, 42
Filing
79279475
Registration
6297517
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
03/24/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
01/09/2020
Registration date
03/23/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/23/2021
Last transaction
03/24/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
FRIZALONE, SARAH O
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
AdrenoMed AG
Representatives
Dennis S. Prahl Ladas & Parry, LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for rescuing vascular integrity in acute life-threatening conditions requiring hospitalization such as sepsisseptic shockcardiogenic shockacute heart failure; antiseptic preparations; antibodies for use as drugs for safeguarding vascular integrity
Class 42
Medical research in the treatment of sepsisseptic shockcardiogenic shock and acute heart failure; development of pharmaceutical preparationtherapeutic antibodies targeting loss of vascular integrity
Publications
History of USPTO decisions and trademark events.
29 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/18/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/29/2021
FIMP
FINAL DISPOSITION PROCESSED
06/29/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/23/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/23/2021
GPNX
NOTIFICATION PROCESSED BY IB
01/10/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/05/2021
PUBO
PUBLISHED FOR OPPOSITION
01/05/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/23/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/23/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/16/2020
ALIE
ASSIGNED TO LIE
11/30/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/30/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/18/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/18/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/18/2020
RFNT
REFUSAL PROCESSED BY IB
06/05/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/20/2020
RFRR
REFUSAL PROCESSED BY MPU
05/20/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/07/2020
CNRT
NON-FINAL ACTION WRITTEN
05/06/2020
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
05/04/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/22/2020
CNRT
NON-FINAL ACTION WRITTEN
04/21/2020
DOCK
ASSIGNED TO EXAMINER
03/09/2020
MAFR
APPLICATION FILING RECEIPT MAILED
03/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/28/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/27/2020
Continuous trademark protection
Get notified about every new filing that threatens ADRENOMED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.